{"gene":"NDP","run_date":"2026-06-10T05:19:52","timeline":{"discoveries":[{"year":2004,"finding":"Norrin (NDP) functions as a high-affinity ligand for Frizzled-4 (Fz4) receptor, binding specifically to Fz4 and not other Frizzled family members, and activates the classical (canonical) Wnt/β-catenin pathway in an Fz4- and Lrp-dependent manner. Disease-associated variants of Norrin and Fz4 display signaling defects.","method":"Binding assays, cell-based canonical Wnt pathway reporter assays, genetic phenotype comparison between Norrin and Fz4 mutant mice and humans","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (binding assay, cell-based signaling assay, in vivo genetics), replicated across species, foundational study","pmids":["15035989"],"is_preprint":false},{"year":2009,"finding":"TSPAN12 (tetraspanin-12) associates with the Norrin/Frizzled4 receptor complex, promotes multimerization of FZD4 and associated proteins, and selectively amplifies Norrin/β-catenin signaling but not Wnt/β-catenin signaling. TSPAN12 siRNA abolishes transcriptional responses to Norrin but not Wnt3A in retinal endothelial cells. TSPAN12 loss-of-function phenocopies Norrin, Fzd4, and Lrp5 mutant retinal vascular defects in mice.","method":"Co-immunoprecipitation, siRNA knockdown, overexpression, mouse genetics (knockout), cell-based β-catenin reporter assays","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (Co-IP, siRNA, OE, in vivo mouse genetics), replicated finding, two independent labs (PMID 19837033 and PMID 28658627)","pmids":["19837033","28658627"],"is_preprint":false},{"year":2009,"finding":"Norrin/Fz4/Lrp signaling acts specifically in endothelial cells to control retinal vascular growth and blood-brain barrier integrity. Sox17, a transcription factor upregulated by Norrin/Fz4/Lrp signaling, plays a central role in inducing the angiogenic program. Excessive Fz4 signaling disrupts embryonic angiogenesis.","method":"Conditional mouse genetics (endothelial-specific Fz4 deletion), cell culture Norrin/Fz4/Lrp signaling assays, gene expression analysis","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific conditional knockout with defined phenotypic readout plus mechanistic follow-up (Sox17 identification), rigorous in vivo and in vitro","pmids":["19837032"],"is_preprint":false},{"year":2012,"finding":"Norrin/Fz4 signaling in adult retinal and cerebellar endothelial cells maintains blood-retina barrier and blood-brain barrier function in a cell-autonomous manner, demonstrating ongoing plasticity and requirement for Frizzled signaling in mature CNS vascular barrier maintenance.","method":"Conditional gain- and loss-of-function mouse genetics, genetic mosaic analysis, vascular permeability assays","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo genetic gain and loss of function with specific barrier permeability readouts, multiple genetic models","pmids":["23217714"],"is_preprint":false},{"year":2015,"finding":"Crystal structure of Norrin in complex with Fz4 cysteine-rich domain (Fz4CRD) revealed that Norrin mimics Wnt for Frizzled recognition, using structurally distinct patches to contact Fz4. The structure maps separate binding sites on Norrin for Fz4 and Lrp5/6, and identifies a glycosaminoglycan (GAG) binding site spanning Norrin and Fz4CRD. Disease-associated mutations are explained by these structural findings.","method":"X-ray crystallography, small-angle X-ray scattering (SAXS), biophysical binding assays, cell-based signaling assays with mutants","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with functional validation by mutagenesis and cell-based assays, complementary SAXS, rigorous single study","pmids":["26158506"],"is_preprint":false},{"year":2013,"finding":"Crystal structure of Norrin reveals a unique dimeric architecture with each monomer adopting a cystine knot fold. The dimer interface is required for Fz4 activation. Norrin contains separate binding sites for Fz4 and for Lrp5/Lrp6 and induces formation of a ternary Norrin-Fz4-Lrp5/6 complex rather than inducing Fz4 dimerization.","method":"X-ray crystallography, site-directed mutagenesis, co-immunoprecipitation/binding assays, cell-based Wnt reporter assays","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure combined with mutagenesis and functional signaling assays in single rigorous study","pmids":["24186977"],"is_preprint":false},{"year":2006,"finding":"Norrin binds specifically to the Fz4 cysteine-rich domain (CRD) and does not detectably bind to 14 other mammalian Frizzled or secreted Frizzled-related protein CRDs. Norrin and Xenopus Wnt8 recognize largely overlapping regions on the Fz4 CRD. Norrin binding depends critically on three disulfide bonds forming the cystine knot and on a largely contiguous group of amino acids in the extended beta-sheet domain. Heparin enhances Norrin-CRD binding ~10-fold.","method":"Binding specificity assays across 14 Frizzled CRDs, site-directed mutagenesis of Norrin and Fz4/Fz8 chimeras, heparin competition binding","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — comprehensive mutagenesis combined with systematic binding specificity panel across 14 CRDs, multiple orthogonal methods","pmids":["17158104"],"is_preprint":false},{"year":1997,"finding":"Norrin is a secreted protein that forms disulfide-bonded oligomers (up to ~20 monomers) associated with the extracellular matrix. Cysteine-95 is required for oligomer formation beyond dimers. Disease-associated mutations (V60E, R121Q) reduce the amount of Norrin in the extracellular matrix of transfected cells.","method":"Pulse-chase radiolabeling, SDS-PAGE under reducing and non-reducing conditions, chemical crosslinking, site-directed mutagenesis of Cys95 and disease variants","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — biochemical reconstitution with mutagenesis in transfected cells, single lab but multiple orthogonal biochemical methods","pmids":["9407136"],"is_preprint":false},{"year":2017,"finding":"TSPAN12 acts as a co-receptor for the Norrin/FZD4 signaling complex: it interacts directly with FZD4 and NDP via its extracellular loops, enhances FZD4 ligand selectivity for NDP over Wnt, and is an essential component of the NDP receptor complex. FEVR-linked TSPAN12 mutations prevent its incorporation into the NDP receptor complex. TSPAN12 can rescue defects of FZD4 M105V (a mutation destabilizing NDP/FZD4 interaction) in vitro and in Xenopus.","method":"Co-immunoprecipitation, cell-based signaling assays, FEVR-mutant functional analysis, Xenopus rescue experiments","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, cell-based assay, in vivo Xenopus validation, FEVR mutation analysis, multiple methods in single study","pmids":["28658627"],"is_preprint":false},{"year":2018,"finding":"The flexible linker domain connecting the Fz4 CRD to the transmembrane domain directly contributes to high-affinity Norrin/Fz4 interaction (~10-fold higher affinity than CRD alone). Swapping the Fz4 linker with Fz5 linker abolishes Norrin signaling. Norrin binding induces conformational changes in the Fz4 linker and intracellular loop 3 (ICL3), and ICL3 mutations (L430A, L433A) reduce β-catenin signaling.","method":"Biophysical binding assays (SPR), hydrogen-deuterium exchange mass spectrometry, site-directed mutagenesis, cell-based β-catenin reporter assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — HDX-MS structural dynamics, binding assays, mutagenesis and functional signaling, multiple orthogonal methods in one study","pmids":["30104375"],"is_preprint":false},{"year":2017,"finding":"Norrin triggers FZD4 ubiquitination and induces internalization of the NDP/FZD4 receptor complex into the endo-lysosomal compartment via the multivesicular body (MVB)/ESCRT pathway. Inhibiting ubiquitinated cargo transport through the MVB pathway (dominant-negative VPS4 EQ) strongly impairs NDP/FZD4 β-catenin signaling in vitro and causes CNS angiogenesis and blood-CNS barrier defects in mice.","method":"Ubiquitination assays, endocytosis/trafficking assays, dominant-negative ESCRT overexpression (VPS4 EQ), in vitro signaling assays, in vivo mouse vascular phenotyping","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Moderate — mechanistic trafficking experiments with dominant-negative validated both in vitro and in vivo, multiple orthogonal approaches","pmids":["28675177"],"is_preprint":false},{"year":2010,"finding":"Norrin activates Wnt/β-catenin signaling in Müller glia, which then induces neuroprotective growth factors (FGF2, BDNF, CNTF, LEGF, LIF, EDN2). Conditioned medium from Norrin-treated Müller cells increases survival of RGC-5 cells. These neuroprotective effects on retinal ganglion cells can be blocked by DKK-1 (a Wnt/β-catenin inhibitor).","method":"Intravitreal injection of Norrin + NMDA in mice, DKK-1 inhibitor experiments, primary Müller cell culture, conditioned medium transfer to RGC-5 cells, western blot and gene expression analysis","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo and in vitro with DKK-1 blockade, conditioned medium transfer, single lab, multiple methods","pmids":["20427659"],"is_preprint":false},{"year":2010,"finding":"Norrin stimulates proliferation, viability, migration, and tube formation of microvascular endothelial cells in vitro. These effects are blocked by DKK-1. Norrin induces angiopoietin-2 (Ang-2) expression, and inhibitory antibodies against Ang-2 suppress Norrin's proliferative effects, placing Ang-2 as a downstream mediator.","method":"In vitro endothelial cell assays (proliferation, migration, tube formation), DKK-1 inhibition, anti-Ang-2 antibody inhibition, transgenic mouse OIR model","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple in vitro functional assays with DKK-1 pathway blockade and Ang-2 antibody inhibition, in vivo transgenic validation","pmids":["20053900"],"is_preprint":false},{"year":2013,"finding":"Norrin acts as a ligand for LGR4 receptor and stimulates Wnt signaling mediated by LGR4 (but not LGR5 or LGR6) in mammalian cells. Binding studies showed interactions between Norrin and LGR4, LGR5, and LGR6, but only LGR4 mediates signaling. Different Norrie disease mutations can be categorized by defects in signaling through FZD4 vs. LGR4 vs. BMP antagonism pathways.","method":"Cell-based Wnt signaling assays, binding studies, site-directed mutagenesis categorizing disease mutants","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-based signaling and binding assays with multiple receptor comparisons, mutagenesis, single lab","pmids":["23444378"],"is_preprint":false},{"year":2018,"finding":"Wnt7a and Norrin systems show partial redundancy in maintaining the blood-brain barrier and blood-retina barrier. Combined loss of Wnt7a and Norrin (or Wnt7a and Fz4) produces far more severe BBB defects than individual losses. Tspan12 functions as a coactivator less potent than Norrin in BBB maintenance, consistent with a model where Tspan12 amplifies Norrin signal amplitude in endothelial cells.","method":"Compound conditional knockout mouse genetics, BBB/BRB permeability assays, epistasis analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — rigorous compound conditional genetic epistasis in vivo with quantitative barrier assays, multiple genetic combinations tested","pmids":["30478038"],"is_preprint":false},{"year":2019,"finding":"A molecularly defined subset of cortical astroglia (enriched in layer V) expresses and secretes Norrin. Astrocytic Norrin regulates neuronal dendrites and dendritic spines; loss of Norrin (as in Norrie disease) contributes to cortical dendritic spine loss.","method":"Transgenic mice with astroglia-specific promoter, transcriptomic analysis, histological analysis, loss-of-function dendritic spine quantification","journal":"Nature neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function with specific structural neuronal readout (spine density), transcriptomic confirmation of expression, single lab","pmids":["30936556"],"is_preprint":false},{"year":2014,"finding":"Norrin protected blood-brain barrier integrity after subarachnoid hemorrhage via Frizzled-4 receptor activation, which promotes β-catenin nuclear translocation and enhances expression of tight junction proteins Occludin, VE-Cadherin, and ZO-1. These effects were abolished by Frizzled-4 siRNA pretreatment.","method":"Rat subarachnoid hemorrhage model, intracerebroventricular Norrin administration, Frizzled-4 siRNA knockdown, BBB permeability assays, western blot, immunofluorescence","journal":"Stroke","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown of receptor abolishes Norrin effect, in vivo model with functional readouts, single lab","pmids":["25550365"],"is_preprint":false},{"year":2020,"finding":"Norrin restores blood-retinal barrier properties after VEGF-induced permeability in a β-catenin-dependent manner. VEGF promotes Norrin responsiveness by increasing TSPAN12 at cell membranes via an MEK/ERK-dependent mechanism. Norrin and VEGF together (but not separately) are required for enriched claudin-5 localization at tight junctions. GSK-3α/β inhibition does not restore BRB properties, suggesting the mechanism is not through GSK-3 inhibition alone.","method":"In vitro primary endothelial cell barrier assays (electrical resistance, RITC-dextran permeability), intravitreal co-injection in diabetic rats, western blot, β-catenin reporter assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro and in vivo barrier assays, pathway inhibitor experiments, single lab with multiple orthogonal methods","pmids":["32086377"],"is_preprint":false},{"year":2005,"finding":"Ectopic transgenic expression of Norrin under a lens-specific promoter restores normal retinal vascular network formation in Norrie disease (Ndp knockout) mice, rescuing the failure of deep capillary layer formation. Lenses expressing ectopic Norrin induce proliferation of co-cultured microvascular endothelial cells in vitro.","method":"Transgenic rescue in Ndp knockout mice, retinal vascular morphology, ERG functional analysis, in vitro co-culture endothelial proliferation assay","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vivo transgenic rescue of specific vascular phenotype with functional (ERG) readout, plus in vitro proliferation assay, single lab but strong rescue experiment","pmids":["15716406"],"is_preprint":false},{"year":2012,"finding":"Norrin is expressed in Müller glia in the retina and activates canonical Wnt/β-catenin signaling through Frizzled-4 receptors. Loss of Norrin or Frizzled-4 prevents intraretinal capillary formation during developmental angiogenesis. Norrin stimulates endothelial cell proliferation in the superficial retinal vascular plexus, and loss of Norrin reduces proliferation of isolectin B4-positive endothelial cells. Elevated mural cell coverage in Ndp knockout mice is associated with altered PDGFβ and PDGFRβ expression.","method":"Ndp knockout mouse morphometric analysis, DAPT Notch inhibition, BrdU in vivo proliferation assays, PDGF pathway expression analysis","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo knockout with quantitative vascular morphometry and proliferation assays, single lab","pmids":["22394677"],"is_preprint":false},{"year":2010,"finding":"In FZD4 CRD mutants associated with FEVR (C45Y, Y58C, C204R), Norrin binding to FZD4 is abolished and FZD4-mediated Wnt/β-catenin signaling is abrogated. In vivo validation in Xenopus embryos showed these FZD4 mutations disrupt Norrin/β-catenin signaling as evidenced by decreased Siamois and Xnr3 expression.","method":"Cell-surface and overlay binding assays, luciferase reporter assays in HEK293, in vivo Xenopus β-catenin target gene expression","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — binding and signaling assays with disease mutants, in vivo Xenopus validation, single lab","pmids":["21177847"],"is_preprint":false},{"year":2007,"finding":"Missense mutations in NDP found in FEVR patients caused variable but moderate reductions (rather than complete abolishment) in Norrin signaling activity in a Topflash reporter assay. Norrin mutants examined demonstrated impaired cell surface binding to FZD4, and some may have partially lost ability to form a complex with high molecular weight material(s). No single-missense Norrin mutant showed complete loss of signaling.","method":"Norrin-dependent Topflash reporter assay, cell surface binding assay, protein electrophoresis","journal":"Human genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic functional analysis of multiple patient variants with both binding and signaling assays, single lab","pmids":["17955262"],"is_preprint":false},{"year":2024,"finding":"Glutamatergic neuronal activity regulates retinal angiogenesis and blood-retinal barrier maturation by modulating endothelial Norrin/β-catenin signaling. In Vglut1-/- retinas (where neurons fail to release glutamate), Norrin expression and endothelial Norrin/β-catenin signaling are downregulated; in Gnat1-/- retinas (excessive glutamate), they are upregulated. Pharmacological activation of endothelial Norrin/β-catenin signaling in Vglut1-/- retinas rescues deep plexus angiogenesis and paracellular BRB maturation defects.","method":"In vivo mouse genetic studies (Vglut1-/-, Gnat1-/- knockouts), scRNA-seq, pharmacological Norrin/β-catenin pathway activation, vascular morphometry and permeability assays","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with specific pathway rescue (pharmacological activation), scRNA-seq, multiple orthogonal methods in one rigorous study","pmids":["38599212"],"is_preprint":false},{"year":2019,"finding":"Dermal papilla cells (DPCs) stimulated by extracellular vesicles from activated dermal fibroblasts upregulate and secrete Norrin via the NDP gene, which then activates the β-catenin pathway in follicular keratinocytes in a non-cell-autonomous manner to promote hair follicle growth. FZD4 protein (delivered by EV) was required to potentiate Norrin effects.","method":"Transcriptomic analysis of DPCs, siRNA knockdown, β-catenin reporter assays, hair follicle ex vivo growth assays, EV transfer","journal":"Stem cells (Dayton, Ohio)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transcriptomics plus functional cell-based assays and ex vivo model, single lab","pmids":["31237401"],"is_preprint":false},{"year":2020,"finding":"In glioblastoma, Norrin signals through FZD4 to activate canonical Wnt signaling in ASCL1-low GSCs (tumor-suppressive effect) but promotes Notch signaling independently of WNT in ASCL1-high GSCs (tumor-promoting effect). Forced ASCL1 expression reversed tumor-suppressive effects of Norrin in ASCL1-low GSCs.","method":"GBM stem cell culture, NDP/FZD4 manipulation, Notch and Wnt pathway reporter assays, ASCL1 overexpression rescue, functional growth assays","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-based gain/loss of function with pathway-specific readouts and rescue experiment, single lab","pmids":["32182224"],"is_preprint":false},{"year":2021,"finding":"A tetravalent bispecific antibody (F4L5.13) designed to induce FZD4 and LRP5 proximity triggers β-catenin signaling in endothelial cells, rescues retinal angiogenesis and barrier function in Tspan12-/- mice, and normalizes neovascularization in an OIR model, demonstrating that forced FZD4-LRP5 co-engagement is sufficient to recapitulate Norrin/FZD4/LRP5 signaling.","method":"Antibody engineering, cell-based β-catenin signaling assays, Tspan12-/- mouse retinal phenotype rescue, OIR mouse model, vascular permeability assays","journal":"EMBO molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro and in vivo rescue with mechanistic antibody tool demonstrating sufficiency of FZD4-LRP5 co-engagement, single lab","pmids":["34105895"],"is_preprint":false},{"year":2005,"finding":"Female mice homozygous for Ndp knockout exhibit near-complete infertility due to defects in vascular development and decidualization in the uterus from E7 onwards, demonstrating a role for Norrin in female reproductive tissue vascular development.","method":"Ndp knockout mouse model, histological analysis, RNA in situ hybridization, RT-PCR expression analysis of uteri, deciduae, and human placenta","journal":"Genesis (New York, N.Y. : 2000)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with specific histological and vascular phenotypic readout, expression confirmed by RT-PCR, single lab","pmids":["16035034"],"is_preprint":false},{"year":2012,"finding":"Norrin activates Wnt/β-catenin signaling and endothelin-2 (EDN2) signaling to protect photoreceptors from light-induced damage. The protective effects were abolished by intravitreal injection of DKK-1 (Wnt/β-catenin inhibitor) or BQ788 (EDN receptor B antagonist), establishing that both Wnt/β-catenin and EDN2 signaling are required for Norrin-mediated photoreceptor protection.","method":"Transgenic Norrin-overexpressing mice (Rpe65-Norrin), light damage model, intravitreal DKK-1 and BQ788 injections, ERG functional assays, apoptosis quantification","journal":"Neurobiology of disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo pathway blockade with two different inhibitors to dissect mechanisms, transgenic model, functional readouts, single lab","pmids":["23009755"],"is_preprint":false},{"year":2015,"finding":"Norrin induces IGF-1 expression via activation of the Wnt/β-catenin signaling pathway in Müller cells and endothelial cells. Inhibition of IGF-1 with antibodies significantly attenuates Norrin-mediated vascular repair in the OIR model, establishing IGF-1 as a downstream mediator of Norrin's angiogenic properties.","method":"Transgenic Norrin-overexpressing mice (βB1-Norrin), OIR model, DKK-1 inhibition, anti-IGF-1 antibody intravitreal injection, gene expression analysis","journal":"Experimental eye research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — inhibitory antibody intervention establishing downstream mediator role, in vivo and in vitro, single lab","pmids":["26706283"],"is_preprint":false}],"current_model":"Norrin (NDP) is a secreted cystine-knot growth factor that forms disulfide-linked dimers/oligomers associated with the extracellular matrix; it acts as an atypical, high-affinity ligand for Frizzled-4 (FZD4) receptor — specifically binding its cysteine-rich domain in a manner that mimics Wnt — and, together with the LRP5/6 co-receptors and the tetraspanin co-receptor TSPAN12, assembles a ternary signaling complex that activates the canonical β-catenin/Wnt pathway in vascular endothelial cells of the retina and CNS to drive angiogenesis, blood-retina and blood-brain barrier formation and maintenance, and (via β-catenin-dependent induction of growth factors such as FGF2, BDNF, Ang-2, and IGF-1 in Müller glia) neuroprotection of retinal ganglion cells; Norrin-induced FZD4 ubiquitination and endo-lysosomal trafficking through the ESCRT/MVB pathway is required for full signaling, and Norrin also signals through LGR4 and, in some contexts, activates Notch independently of Wnt."},"narrative":{"mechanistic_narrative":"Norrin (NDP) is a secreted cystine-knot growth factor that drives canonical Wnt/β-catenin signaling in vascular endothelium to control CNS and retinal angiogenesis and blood-barrier formation and maintenance [PMID:15035989, PMID:19837032, PMID:23217714]. Biochemically it is secreted as disulfide-bonded dimers and higher-order oligomers associated with the extracellular matrix, with Cys95 required for oligomerization beyond dimers [PMID:9407136]; each monomer adopts a cystine-knot fold, and the dimer interface is required for receptor activation [PMID:24186977]. Norrin acts as an atypical, Wnt-mimetic ligand that binds specifically and with high affinity to the cysteine-rich domain (CRD) of Frizzled-4 and not to other Frizzled CRDs, contacting Fz4 through patches that overlap the Wnt-recognition surface while using a separate site to engage the LRP5/6 co-receptor, thereby nucleating a ternary Norrin–Fz4–LRP5/6 complex rather than inducing Fz4 dimerization [PMID:15035989, PMID:26158506, PMID:24186977, PMID:17158104]. Signaling output is selectively amplified by the tetraspanin co-receptor TSPAN12, which interacts directly with FZD4 and Norrin, promotes receptor-complex multimerization, and confers ligand selectivity for Norrin over Wnt [PMID:19837033, PMID:28658627]. Norrin-induced FZD4 ubiquitination and trafficking of the receptor complex into the endo-lysosomal/MVB compartment via the ESCRT pathway is required for full β-catenin signaling and for normal CNS vascular and barrier development [PMID:28675177]. Downstream, endothelial β-catenin activation induces an angiogenic and barrier program—including Sox17 and tight-junction proteins—while in Müller glia Norrin/β-catenin drives secretion of neuroprotective and angiogenic factors (FGF2, BDNF, Ang-2, IGF-1) that support endothelial growth and retinal neuron survival [PMID:19837032, PMID:20427659, PMID:20053900, PMID:26706283]. Loss-of-function and disease-associated NDP and FZD4 variants disrupt secretion, receptor binding, or signaling, and transgenic re-expression of Norrin rescues retinal vascular defects in Ndp-null mice, establishing Norrin as causative for the inherited vascular retinopathies of the Norrie disease/FEVR spectrum [PMID:9407136, PMID:15716406, PMID:21177847, PMID:17955262]. Beyond the vascular Wnt axis, Norrin also signals through the LGR4 receptor and, in glioblastoma stem cells, can activate Notch independently of Wnt depending on ASCL1 status [PMID:23444378, PMID:32182224].","teleology":[{"year":1997,"claim":"Established the secreted, oligomeric, ECM-associated nature of Norrin before its receptor was known, defining the biochemical form in which the ligand acts.","evidence":"Pulse-chase radiolabeling, non-reducing SDS-PAGE, crosslinking and mutagenesis of Cys95 and disease variants in transfected cells","pmids":["9407136"],"confidence":"High","gaps":["Did not identify a receptor or signaling pathway","Functional consequence of oligomerization for signaling not tested"]},{"year":2004,"claim":"Identified Norrin as a high-affinity, Frizzled-4-specific ligand that activates canonical Wnt/β-catenin signaling in an Fz4/Lrp-dependent manner, unifying NDP and FZD4 genetics into one pathway.","evidence":"Binding assays, cell-based β-catenin reporter assays, and comparison of Norrin and Fz4 mutant mice and humans","pmids":["15035989"],"confidence":"High","gaps":["Structural basis of Fz4 selectivity not resolved","Co-receptor requirements beyond Lrp not defined"]},{"year":2006,"claim":"Defined the structural determinants of Norrin–Fz4 specificity, showing it recognizes the Fz4 CRD over 13 other CRDs through the cystine knot and overlaps the Wnt8 binding region, with heparin enhancing binding.","evidence":"Binding specificity panel across 14 Frizzled CRDs, mutagenesis of Norrin and Fz4/Fz8 chimeras, heparin competition","pmids":["17158104"],"confidence":"High","gaps":["Atomic structure not yet determined","Role of GAG binding in vivo unknown"]},{"year":2009,"claim":"Showed Norrin/Fz4/Lrp signaling acts cell-autonomously in endothelium to drive retinal vascular growth and barrier integrity, identifying Sox17 as a transcriptional effector of the angiogenic program.","evidence":"Endothelial-specific conditional Fz4 deletion, cell-culture signaling assays, gene expression analysis","pmids":["19837032"],"confidence":"High","gaps":["Full downstream transcriptional network not mapped","Mechanism of barrier-specific output not resolved"]},{"year":2009,"claim":"Identified TSPAN12 as a component that multimerizes the Norrin/FZD4 complex and selectively amplifies Norrin (not Wnt) β-catenin signaling, explaining ligand-specific pathway control.","evidence":"Co-IP, siRNA knockdown, overexpression, mouse knockout phenocopy, β-catenin reporter assays","pmids":["19837033","28658627"],"confidence":"High","gaps":["Molecular basis of Norrin-vs-Wnt selectivity not yet structural","Stoichiometry of the multimeric complex unknown"]},{"year":2010,"claim":"Connected Norrin/β-catenin signaling to non-cell-autonomous outputs: Müller-glial induction of neuroprotective factors and endothelial proliferation/angiogenesis mediated by Ang-2.","evidence":"Intravitreal Norrin, DKK-1 blockade, conditioned-medium transfer, anti-Ang-2 inhibition, in vitro endothelial assays, OIR model","pmids":["20427659","20053900"],"confidence":"Medium","gaps":["RGC-5 line and conditioned-medium model are indirect","Relative contributions of individual secreted factors not dissected"]},{"year":2012,"claim":"Demonstrated a continuing requirement for Norrin/Fz4 signaling in mature CNS endothelium for ongoing blood-retina and blood-brain barrier maintenance, not just development.","evidence":"Conditional gain/loss-of-function and mosaic mouse genetics with vascular permeability assays","pmids":["23217714"],"confidence":"High","gaps":["Molecular targets sustaining the mature barrier not fully enumerated"]},{"year":2013,"claim":"Determined the Norrin crystal structure, establishing a cystine-knot dimer with separate Fz4 and Lrp5/6 sites that assembles a ternary complex, providing the mechanistic framework for receptor engagement.","evidence":"X-ray crystallography, mutagenesis, binding assays, Wnt reporter assays","pmids":["24186977"],"confidence":"High","gaps":["Co-complex structure with receptors not yet solved","Conformational changes in Fz4 upon binding not visualized"]},{"year":2013,"claim":"Revealed receptor diversity by showing Norrin also functions as an LGR4-specific Wnt agonist, and that disease mutations can be partitioned by which downstream pathway they impair.","evidence":"Cell-based Wnt signaling and binding assays across LGR4/5/6, mutagenesis of disease variants","pmids":["23444378"],"confidence":"Medium","gaps":["In vivo physiological role of Norrin–LGR4 signaling not established","Relationship to FZD4 axis unclear"]},{"year":2015,"claim":"Provided the Norrin–Fz4CRD co-structure, showing Wnt mimicry through distinct contact patches, mapped separate Lrp5/6 and GAG sites, and explained disease mutations structurally.","evidence":"X-ray crystallography, SAXS, biophysical binding and cell-based signaling assays with mutants","pmids":["26158506"],"confidence":"High","gaps":["Full ternary receptor complex not captured","Transmembrane signal transmission not addressed"]},{"year":2017,"claim":"Established TSPAN12 as a direct co-receptor whose extracellular loops bind FZD4 and Norrin to confer ligand selectivity, and showed FEVR mutations exclude it from the complex.","evidence":"Reciprocal Co-IP, cell-based signaling, FEVR-mutant analysis, Xenopus rescue","pmids":["28658627"],"confidence":"High","gaps":["Structure of TSPAN12 within the complex unknown","Quantitative contribution to receptor multimerization unresolved"]},{"year":2017,"claim":"Showed that Norrin-triggered FZD4 ubiquitination and ESCRT/MVB-dependent endo-lysosomal trafficking is required for full β-catenin signaling and CNS vascular development, adding a post-receptor regulatory layer.","evidence":"Ubiquitination/trafficking assays, dominant-negative VPS4 EQ, in vitro signaling and in vivo mouse vascular phenotyping","pmids":["28675177"],"confidence":"High","gaps":["Identity of the responsible E3 ligase not defined","How trafficking enhances β-catenin output mechanistically unclear"]},{"year":2018,"claim":"Refined the receptor mechanism by showing the Fz4 stalk linker contributes ~10-fold to Norrin affinity and that binding induces conformational changes in the linker and ICL3 important for signaling.","evidence":"SPR binding, HDX-MS, mutagenesis (linker swaps, ICL3 mutants), β-catenin reporter assays","pmids":["30104375"],"confidence":"High","gaps":["How ICL3 changes couple to intracellular effectors not defined"]},{"year":2018,"claim":"Defined functional redundancy between the Norrin and Wnt7a barrier systems, and positioned TSPAN12 as a less-potent coactivator that tunes Norrin signal amplitude.","evidence":"Compound conditional knockout epistasis, BBB/BRB permeability assays","pmids":["30478038"],"confidence":"High","gaps":["Regional/temporal division of labor between ligands not fully mapped"]},{"year":2019,"claim":"Extended Norrin biology beyond vasculature, showing astroglial-secreted Norrin shapes neuronal dendrites/spines and that follicular Norrin acts non-cell-autonomously to drive hair growth.","evidence":"Astroglia-specific transgenics with spine quantification; dermal papilla transcriptomics, siRNA, β-catenin reporters, ex vivo hair follicle growth and EV transfer","pmids":["30936556","31237401"],"confidence":"Medium","gaps":["Receptor/co-receptor identity in these contexts not fully defined","Single-lab observations"]},{"year":2020,"claim":"Revealed context-dependent pathway switching: Norrin activates Wnt in ASCL1-low glioblastoma stem cells but Notch independently of Wnt in ASCL1-high cells, with opposite tumor consequences; and VEGF licenses Norrin barrier responses via MEK/ERK-driven TSPAN12 surface expression.","evidence":"GSC cultures with NDP/FZD4 manipulation and ASCL1 rescue; endothelial barrier assays with VEGF co-treatment, pathway inhibitors, diabetic rat injections","pmids":["32182224","32086377"],"confidence":"Medium","gaps":["Molecular switch determining Wnt-vs-Notch output unclear","GSK-3-independent barrier mechanism not fully resolved"]},{"year":2021,"claim":"Demonstrated sufficiency of the core receptor logic: a bispecific antibody forcing FZD4–LRP5 proximity recapitulates Norrin signaling and rescues Tspan12-/- and OIR vascular defects.","evidence":"Antibody engineering, β-catenin assays, Tspan12-/- rescue, OIR model, permeability assays","pmids":["34105895"],"confidence":"Medium","gaps":["Whether forced proximity reproduces full trafficking-dependent signaling not tested","Single lab"]},{"year":2024,"claim":"Placed Norrin signaling under neuronal-activity control, showing glutamatergic activity tunes endothelial Norrin/β-catenin signaling to coordinate angiogenesis and barrier maturation with neural function.","evidence":"Vglut1-/- and Gnat1-/- mouse genetics, scRNA-seq, pharmacological pathway activation, vascular morphometry and permeability","pmids":["38599212"],"confidence":"High","gaps":["Signal relay from glutamate sensing to Norrin expression not molecularly defined"]},{"year":null,"claim":"How the choice between Norrin's distinct outputs (FZD4/β-catenin vs LGR4 vs Notch) is determined in different cell contexts, and the identity of the FZD4 E3 ubiquitin ligase coupling trafficking to signal strength, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No defined molecular switch governing pathway selection","FZD4 ubiquitin ligase unidentified","In vivo role of Norrin-LGR4 axis untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[0,4,5,6,13]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,8]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,5]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[6,4]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[7,15,23]},{"term_id":"GO:0031012","term_label":"extracellular matrix","supporting_discovery_ids":[7]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,5,9]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[2,18,19]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[10]}],"complexes":["Norrin-FZD4-LRP5/6 ternary signaling complex","Norrin/FZD4/TSPAN12 receptor complex"],"partners":["FZD4","LRP5","LRP6","TSPAN12","LGR4"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q00604","full_name":"Norrin","aliases":["Norrie disease protein","X-linked exudative vitreoretinopathy 2 protein"],"length_aa":133,"mass_kda":15.0,"function":"Activates the canonical Wnt signaling pathway through FZD4 and LRP5 coreceptor. Plays a central role in retinal vascularization by acting as a ligand for FZD4 that signals via stabilizing beta-catenin (CTNNB1) and activating LEF/TCF-mediated transcriptional programs. Acts in concert with TSPAN12 to activate FZD4 independently of the Wnt-dependent activation of FZD4, suggesting the existence of a Wnt-independent signaling that also promote accumulation the beta-catenin (CTNNB1). May be involved in a pathway that regulates neural cell differentiation and proliferation. Possible role in neuroectodermal cell-cell interaction","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/Q00604/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NDP","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NDP","total_profiled":1310},"omim":[{"mim_id":"620191","title":"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, DYSMORPHIC FACIES, AND SKIN ABNORMALITIES; NEDHFS","url":"https://www.omim.org/entry/620191"},{"mim_id":"618584","title":"NME/NM23 FAMILY, MEMBER 9; NME9","url":"https://www.omim.org/entry/618584"},{"mim_id":"617804","title":"NEURODEVELOPMENTAL DISORDER WITH VARIABLE MOTOR AND LANGUAGE IMPAIRMENT; NEDMIAL","url":"https://www.omim.org/entry/617804"},{"mim_id":"616423","title":"DExH-BOX HELICASE 30; DHX30","url":"https://www.omim.org/entry/616423"},{"mim_id":"613138","title":"TETRASPANIN 12; TSPAN12","url":"https://www.omim.org/entry/613138"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Vesicles","reliability":"Supported"},{"location":"Nucleoplasm","reliability":"Additional"},{"location":"Nucleoli","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":32.4},{"tissue":"ovary","ntpm":31.8}],"url":"https://www.proteinatlas.org/search/NDP"},"hgnc":{"alias_symbol":["norrin"],"prev_symbol":["EVR2"]},"alphafold":{"accession":"Q00604","domains":[{"cath_id":"2.10.90.10","chopping":"39-47_57-70_91-133","consensus_level":"medium","plddt":95.8348,"start":39,"end":133}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q00604","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q00604-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q00604-F1-predicted_aligned_error_v6.png","plddt_mean":83.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NDP","jax_strain_url":"https://www.jax.org/strain/search?query=NDP"},"sequence":{"accession":"Q00604","fasta_url":"https://rest.uniprot.org/uniprotkb/Q00604.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q00604/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q00604"}},"corpus_meta":[{"pmid":"15035989","id":"PMC_15035989","title":"Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair.","date":"2004","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/15035989","citation_count":730,"is_preprint":false},{"pmid":"19837032","id":"PMC_19837032","title":"Norrin, frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization.","date":"2009","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/19837032","citation_count":379,"is_preprint":false},{"pmid":"23217714","id":"PMC_23217714","title":"Norrin/Frizzled4 signaling in retinal vascular development and blood brain barrier plasticity.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/23217714","citation_count":332,"is_preprint":false},{"pmid":"19837033","id":"PMC_19837033","title":"TSPAN12 regulates retinal vascular development by promoting Norrin- but not Wnt-induced FZD4/beta-catenin signaling.","date":"2009","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/19837033","citation_count":329,"is_preprint":false},{"pmid":"8252044","id":"PMC_8252044","title":"A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy.","date":"1993","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8252044","citation_count":284,"is_preprint":false},{"pmid":"12506203","id":"PMC_12506203","title":"NDP kinase 2 interacts with two oxidative stress-activated MAPKs to regulate cellular redox state and enhances multiple stress tolerance in transgenic plants.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12506203","citation_count":274,"is_preprint":false},{"pmid":"20688566","id":"PMC_20688566","title":"The Norrin/Frizzled4 signaling pathway in retinal vascular development and disease.","date":"2010","source":"Trends in molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20688566","citation_count":149,"is_preprint":false},{"pmid":"10484772","id":"PMC_10484772","title":"Coats' disease of the retina (unilateral retinal telangiectasis) caused by somatic mutation in the NDP gene: a role for norrin in retinal angiogenesis.","date":"1999","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10484772","citation_count":142,"is_preprint":false},{"pmid":"30478038","id":"PMC_30478038","title":"Interplay of the Norrin and Wnt7a/Wnt7b signaling systems in blood-brain barrier and blood-retina barrier development and maintenance.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/30478038","citation_count":133,"is_preprint":false},{"pmid":"20340138","id":"PMC_20340138","title":"Overview of the mutation spectrum in familial exudative vitreoretinopathy and Norrie disease with identification of 21 novel variants in FZD4, LRP5, and NDP.","date":"2010","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/20340138","citation_count":126,"is_preprint":false},{"pmid":"20427659","id":"PMC_20427659","title":"Norrin mediates neuroprotective effects on retinal ganglion cells via activation of the Wnt/beta-catenin signaling pathway and the induction of neuroprotective growth factors in Muller cells.","date":"2010","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20427659","citation_count":113,"is_preprint":false},{"pmid":"26158506","id":"PMC_26158506","title":"Structure and functional properties of Norrin mimic Wnt for signalling with Frizzled4, Lrp5/6, and proteoglycan.","date":"2015","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/26158506","citation_count":109,"is_preprint":false},{"pmid":"24186977","id":"PMC_24186977","title":"Structure and function of Norrin in assembly and activation of a Frizzled 4-Lrp5/6 complex.","date":"2013","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/24186977","citation_count":103,"is_preprint":false},{"pmid":"12848339","id":"PMC_12848339","title":"Multiple biochemical activities of NM23/NDP kinase in gene regulation.","date":"2003","source":"Journal of bioenergetics and biomembranes","url":"https://pubmed.ncbi.nlm.nih.gov/12848339","citation_count":96,"is_preprint":false},{"pmid":"17158104","id":"PMC_17158104","title":"Mutational analysis of Norrin-Frizzled4 recognition.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17158104","citation_count":95,"is_preprint":false},{"pmid":"31660977","id":"PMC_31660977","title":"NDP-MSH binding melanocortin-1 receptor ameliorates neuroinflammation and BBB disruption through CREB/Nr4a1/NF-κB pathway after intracerebral hemorrhage in mice.","date":"2019","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/31660977","citation_count":87,"is_preprint":false},{"pmid":"11121025","id":"PMC_11121025","title":"Catalysis of DNA cleavage and nucleoside triphosphate synthesis by NM23-H2/NDP kinase share an active site that implies a DNA repair function.","date":"2000","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11121025","citation_count":83,"is_preprint":false},{"pmid":"25550365","id":"PMC_25550365","title":"Norrin protected blood-brain barrier via frizzled-4/β-catenin pathway after subarachnoid hemorrhage in rats.","date":"2014","source":"Stroke","url":"https://pubmed.ncbi.nlm.nih.gov/25550365","citation_count":81,"is_preprint":false},{"pmid":"1325378","id":"PMC_1325378","title":"Molecular cloning and functional expression of the second mouse nm23/NDP kinase gene, nm23-M2.","date":"1992","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/1325378","citation_count":81,"is_preprint":false},{"pmid":"28658627","id":"PMC_28658627","title":"TSPAN12 Is a Norrin Co-receptor that Amplifies Frizzled4 Ligand Selectivity and Signaling.","date":"2017","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28658627","citation_count":79,"is_preprint":false},{"pmid":"10632374","id":"PMC_10632374","title":"Overexpression of nm23-H2/NDP kinase B in a human oral squamous cell carcinoma cell line results in reduced metastasis, differentiated phenotype in the metastatic site, and growth factor-independent proliferative activity in culture.","date":"1999","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/10632374","citation_count":79,"is_preprint":false},{"pmid":"15716406","id":"PMC_15716406","title":"Ectopic norrin induces growth of ocular capillaries and restores normal retinal angiogenesis in Norrie disease mutant mice.","date":"2005","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15716406","citation_count":75,"is_preprint":false},{"pmid":"11737268","id":"PMC_11737268","title":"Sptrx-2, a fusion protein composed of one thioredoxin and three tandemly repeated NDP-kinase domains is expressed in human testis germ cells.","date":"2001","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/11737268","citation_count":75,"is_preprint":false},{"pmid":"9924799","id":"PMC_9924799","title":"NM23-NDP kinase.","date":"1998","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/9924799","citation_count":73,"is_preprint":false},{"pmid":"20053900","id":"PMC_20053900","title":"Norrin promotes vascular regrowth after oxygen-induced retinal vessel loss and suppresses retinopathy in mice.","date":"2010","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20053900","citation_count":73,"is_preprint":false},{"pmid":"8386830","id":"PMC_8386830","title":"Expression of nm23/NDP kinase proteins on the cell surface.","date":"1993","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/8386830","citation_count":73,"is_preprint":false},{"pmid":"34561620","id":"PMC_34561620","title":"Structures of active melanocortin-4 receptor-Gs-protein complexes with NDP-α-MSH and setmelanotide.","date":"2021","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/34561620","citation_count":72,"is_preprint":false},{"pmid":"22387751","id":"PMC_22387751","title":"Norrin: molecular and functional properties of an angiogenic and neuroprotective growth factor.","date":"2012","source":"Progress in retinal and eye research","url":"https://pubmed.ncbi.nlm.nih.gov/22387751","citation_count":70,"is_preprint":false},{"pmid":"7479028","id":"PMC_7479028","title":"A human NDP-kinase B specifically binds single-stranded poly-pyrimidine sequences.","date":"1995","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/7479028","citation_count":70,"is_preprint":false},{"pmid":"30936556","id":"PMC_30936556","title":"Molecularly defined cortical astroglia subpopulation modulates neurons via secretion of Norrin.","date":"2019","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30936556","citation_count":69,"is_preprint":false},{"pmid":"33497368","id":"PMC_33497368","title":"Catenin α 1 mutations cause familial exudative vitreoretinopathy by overactivating Norrin/β-catenin signaling.","date":"2021","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/33497368","citation_count":65,"is_preprint":false},{"pmid":"23444378","id":"PMC_23444378","title":"Multi-functional norrin is a ligand for the LGR4 receptor.","date":"2013","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/23444378","citation_count":64,"is_preprint":false},{"pmid":"16970763","id":"PMC_16970763","title":"Mutations in the NDP gene: contribution to Norrie disease, familial exudative vitreoretinopathy and retinopathy of prematurity.","date":"2006","source":"Clinical & experimental ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/16970763","citation_count":63,"is_preprint":false},{"pmid":"10618642","id":"PMC_10618642","title":"A novel human nucleoside diphosphate (NDP) kinase, Nm23-H6, localizes in mitochondria and affects cytokinesis.","date":"1999","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10618642","citation_count":63,"is_preprint":false},{"pmid":"30988181","id":"PMC_30988181","title":"Hypoxia tolerance in the Norrin-deficient retina and the chronically hypoxic brain studied at single-cell resolution.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/30988181","citation_count":61,"is_preprint":false},{"pmid":"21055480","id":"PMC_21055480","title":"Expression of the Norrie disease gene (Ndp) in developing and adult mouse eye, ear, and brain.","date":"2010","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/21055480","citation_count":58,"is_preprint":false},{"pmid":"28494495","id":"PMC_28494495","title":"Mutations in LRP5,FZD4, TSPAN12, NDP, ZNF408, or KIF11 Genes Account for 38.7% of Chinese Patients With Familial Exudative Vitreoretinopathy.","date":"2017","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/28494495","citation_count":58,"is_preprint":false},{"pmid":"34105895","id":"PMC_34105895","title":"A Norrin/Wnt surrogate antibody stimulates endothelial cell barrier function and rescues retinopathy.","date":"2021","source":"EMBO molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34105895","citation_count":56,"is_preprint":false},{"pmid":"9407136","id":"PMC_9407136","title":"Norrie disease protein (norrin) forms disulfide-linked oligomers associated with the extracellular matrix.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9407136","citation_count":55,"is_preprint":false},{"pmid":"23009755","id":"PMC_23009755","title":"Constitutive overexpression of Norrin activates Wnt/β-catenin and endothelin-2 signaling to protect photoreceptors from light damage.","date":"2012","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/23009755","citation_count":54,"is_preprint":false},{"pmid":"12848338","id":"PMC_12848338","title":"Knockout mice as model systems for studying nm23/NDP kinase gene functions. Application to the nm23-M1 gene.","date":"2003","source":"Journal of bioenergetics and biomembranes","url":"https://pubmed.ncbi.nlm.nih.gov/12848338","citation_count":53,"is_preprint":false},{"pmid":"10903994","id":"PMC_10903994","title":"Inhibition by protein kinase C of the K(NDP) subtype of vascular smooth muscle ATP-sensitive potassium channel.","date":"2000","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/10903994","citation_count":49,"is_preprint":false},{"pmid":"8806830","id":"PMC_8806830","title":"The enzymatic activity of Drosophila AWD/NDP kinase is necessary but not sufficient for its biological function.","date":"1996","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/8806830","citation_count":49,"is_preprint":false},{"pmid":"14499630","id":"PMC_14499630","title":"Nm23/NDP kinases in human male germ cells: role in spermiogenesis and sperm motility?","date":"2003","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/14499630","citation_count":45,"is_preprint":false},{"pmid":"30104375","id":"PMC_30104375","title":"Biophysical and functional characterization of Norrin signaling through Frizzled4.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/30104375","citation_count":44,"is_preprint":false},{"pmid":"23468969","id":"PMC_23468969","title":"Effect of NDP-α-MSH on PPAR-γ and -β expression and anti-inflammatory cytokine release in rat astrocytes and microglia.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23468969","citation_count":43,"is_preprint":false},{"pmid":"32086377","id":"PMC_32086377","title":"Norrin restores blood-retinal barrier properties after vascular endothelial growth factor-induced permeability.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32086377","citation_count":41,"is_preprint":false},{"pmid":"31827910","id":"PMC_31827910","title":"Familial Exudative Vitreoretinopathy-Related Disease-Causing Genes and Norrin/β-Catenin Signal Pathway: Structure, Function, and Mutation Spectrums.","date":"2019","source":"Journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/31827910","citation_count":40,"is_preprint":false},{"pmid":"31237401","id":"PMC_31237401","title":"Extracellular Vesicles from Activated Dermal Fibroblasts Stimulate Hair Follicle Growth Through Dermal Papilla-Secreted Norrin.","date":"2019","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/31237401","citation_count":40,"is_preprint":false},{"pmid":"10358040","id":"PMC_10358040","title":"A novel NDP-6-deoxyhexosyl-4-ulose reductase in the pathway for the synthesis of thymidine diphosphate-D-fucose.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10358040","citation_count":39,"is_preprint":false},{"pmid":"28675177","id":"PMC_28675177","title":"Norrin-induced Frizzled4 endocytosis and endo-lysosomal trafficking control retinal angiogenesis and barrier function.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28675177","citation_count":38,"is_preprint":false},{"pmid":"18621712","id":"PMC_18621712","title":"The relationship between dNTP pool levels and mutagenesis in an Escherichia coli NDP kinase mutant.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18621712","citation_count":38,"is_preprint":false},{"pmid":"22394677","id":"PMC_22394677","title":"Norrin stimulates cell proliferation in the superficial retinal vascular plexus and is pivotal for the recruitment of mural cells.","date":"2012","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22394677","citation_count":37,"is_preprint":false},{"pmid":"31220454","id":"PMC_31220454","title":"Müller Cell-Localized G-Protein-Coupled Receptor 81 (Hydroxycarboxylic Acid Receptor 1) Regulates Inner Retinal Vasculature via Norrin/Wnt Pathways.","date":"2019","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/31220454","citation_count":37,"is_preprint":false},{"pmid":"16035034","id":"PMC_16035034","title":"Fetal loss in homozygous mutant Norrie disease mice: a new role of Norrin in reproduction.","date":"2005","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/16035034","citation_count":37,"is_preprint":false},{"pmid":"33274009","id":"PMC_33274009","title":"Activation of the Melanocortin-1 Receptor by NDP-MSH Attenuates Oxidative Stress and Neuronal Apoptosis through PI3K/Akt/Nrf2 Pathway after Intracerebral Hemorrhage in Mice.","date":"2020","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/33274009","citation_count":37,"is_preprint":false},{"pmid":"29181528","id":"PMC_29181528","title":"Mutation Spectrum of the LRP5, NDP, and TSPAN12 Genes in Chinese Patients With Familial Exudative Vitreoretinopathy.","date":"2017","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/29181528","citation_count":34,"is_preprint":false},{"pmid":"21177847","id":"PMC_21177847","title":"An essential role of the cysteine-rich domain of FZD4 in Norrin/Wnt signaling and familial exudative vitreoretinopathy.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21177847","citation_count":33,"is_preprint":false},{"pmid":"14635119","id":"PMC_14635119","title":"NDP gene mutations in 14 French families with Norrie disease.","date":"2003","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/14635119","citation_count":32,"is_preprint":false},{"pmid":"15530864","id":"PMC_15530864","title":"Nm23-M2/NDP kinase B induces endogenous c-myc and nm23-M1/NDP kinase A overexpression in BAF3 cells. Both NDP kinases protect the cells from oxidative stress-induced death.","date":"2004","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/15530864","citation_count":32,"is_preprint":false},{"pmid":"17955262","id":"PMC_17955262","title":"Moderate reduction of Norrin signaling activity associated with the causative missense mutations identified in patients with familial exudative vitreoretinopathy.","date":"2007","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17955262","citation_count":31,"is_preprint":false},{"pmid":"25414188","id":"PMC_25414188","title":"The role of the hypoxia response in shaping retinal vascular development in the absence of Norrin/Frizzled4 signaling.","date":"2014","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/25414188","citation_count":31,"is_preprint":false},{"pmid":"1356959","id":"PMC_1356959","title":"Estrogen receptor, c-erbB-2 and nm23/NDP kinase expression in the intraductal and invasive components of human breast cancers.","date":"1992","source":"Japanese journal of cancer research : Gann","url":"https://pubmed.ncbi.nlm.nih.gov/1356959","citation_count":31,"is_preprint":false},{"pmid":"7928630","id":"PMC_7928630","title":"Immunohistochemical analysis of nm23/NDP kinase expression in human lung adenocarcinoma: association with tumor progression in Clara cell type.","date":"1994","source":"Japanese journal of cancer research : Gann","url":"https://pubmed.ncbi.nlm.nih.gov/7928630","citation_count":30,"is_preprint":false},{"pmid":"29249665","id":"PMC_29249665","title":"FZD4 Marks Lateral Plate Mesoderm and Signals with NORRIN to Increase Cardiomyocyte Induction from Pluripotent Stem Cell-Derived Cardiac Progenitors.","date":"2017","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/29249665","citation_count":28,"is_preprint":false},{"pmid":"38599212","id":"PMC_38599212","title":"Glutamatergic neuronal activity regulates angiogenesis and blood-retinal barrier maturation via Norrin/β-catenin signaling.","date":"2024","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/38599212","citation_count":27,"is_preprint":false},{"pmid":"22230666","id":"PMC_22230666","title":"Protective action of NDP-MSH in experimental subarachnoid hemorrhage.","date":"2012","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/22230666","citation_count":27,"is_preprint":false},{"pmid":"19381783","id":"PMC_19381783","title":"Double knockout Nme1/Nme2 mouse model suggests a critical role for NDP kinases in erythroid development.","date":"2009","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19381783","citation_count":26,"is_preprint":false},{"pmid":"23188723","id":"PMC_23188723","title":"Retinal vascular rescue of oxygen-induced retinopathy in mice by norrin.","date":"2013","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/23188723","citation_count":25,"is_preprint":false},{"pmid":"12829743","id":"PMC_12829743","title":"Receptor activation regulates cortical, but not vesicular localization of NDP kinase.","date":"2003","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/12829743","citation_count":24,"is_preprint":false},{"pmid":"32182224","id":"PMC_32182224","title":"Norrin mediates tumor-promoting and -suppressive effects in glioblastoma via Notch and Wnt.","date":"2020","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/32182224","citation_count":22,"is_preprint":false},{"pmid":"25005225","id":"PMC_25005225","title":"A novel signaling pathway regulates colon cancer angiogenesis through Norrin.","date":"2014","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/25005225","citation_count":22,"is_preprint":false},{"pmid":"12848346","id":"PMC_12848346","title":"Physiological and pathological relevance of extracellular NM23/NDP kinases.","date":"2003","source":"Journal of bioenergetics and biomembranes","url":"https://pubmed.ncbi.nlm.nih.gov/12848346","citation_count":22,"is_preprint":false},{"pmid":"28337179","id":"PMC_28337179","title":"Characterization of a Novel Nicotine Degradation Gene Cluster ndp in Sphingomonas melonis TY and Its Evolutionary Analysis.","date":"2017","source":"Frontiers in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/28337179","citation_count":22,"is_preprint":false},{"pmid":"19373682","id":"PMC_19373682","title":"A novel NDP mutation in an infant with unilateral persistent fetal vasculature and retinal vasculopathy.","date":"2009","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19373682","citation_count":22,"is_preprint":false},{"pmid":"15182694","id":"PMC_15182694","title":"Wnt signaling: Ig-norrin the dogma.","date":"2004","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/15182694","citation_count":21,"is_preprint":false},{"pmid":"16944304","id":"PMC_16944304","title":"Nm23/NDP kinases in hepatocellular carcinoma.","date":"2006","source":"Journal of bioenergetics and biomembranes","url":"https://pubmed.ncbi.nlm.nih.gov/16944304","citation_count":21,"is_preprint":false},{"pmid":"33571638","id":"PMC_33571638","title":"Structure-function relationships in NDP-sugar active SDR enzymes: Fingerprints for functional annotation and enzyme engineering.","date":"2021","source":"Biotechnology advances","url":"https://pubmed.ncbi.nlm.nih.gov/33571638","citation_count":21,"is_preprint":false},{"pmid":"37559903","id":"PMC_37559903","title":"A Frizzled4-LRP5 agonist promotes blood-retina barrier function by inducing a Norrin-like transcriptional response.","date":"2023","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/37559903","citation_count":21,"is_preprint":false},{"pmid":"20600126","id":"PMC_20600126","title":"Interactions of the melanocortin-4 receptor with the peptide agonist NDP-MSH.","date":"2010","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20600126","citation_count":21,"is_preprint":false},{"pmid":"12606760","id":"PMC_12606760","title":"Structural analysis of the activation of ribavirin analogs by NDP kinase: comparison with other ribavirin targets.","date":"2003","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12606760","citation_count":21,"is_preprint":false},{"pmid":"9003348","id":"PMC_9003348","title":"Peripheral retinopathy in offspring of carriers of Norrie disease gene mutations. Possible transplacental effect of abnormal Norrin.","date":"1996","source":"Ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/9003348","citation_count":20,"is_preprint":false},{"pmid":"28823941","id":"PMC_28823941","title":"Norrin treatment improves ganglion cell survival in an oxygen-induced retinopathy model of retinal ischemia.","date":"2017","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/28823941","citation_count":19,"is_preprint":false},{"pmid":"27217716","id":"PMC_27217716","title":"Mutation spectrum of the Norrie disease pseudoglioma (NDP) gene in Indian patients with FEVR.","date":"2016","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/27217716","citation_count":19,"is_preprint":false},{"pmid":"17386109","id":"PMC_17386109","title":"Regulation of norrin receptor frizzled-4 by Wnt2 in colon-derived cells.","date":"2007","source":"BMC cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/17386109","citation_count":19,"is_preprint":false},{"pmid":"19799952","id":"PMC_19799952","title":"The peptide NDP-MSH induces phenotype changes in the heart that resemble ischemic preconditioning.","date":"2009","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/19799952","citation_count":19,"is_preprint":false},{"pmid":"25446929","id":"PMC_25446929","title":"Protective effects of the melanocortin analog NDP-α-MSH in rats undergoing cardiac arrest.","date":"2014","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25446929","citation_count":19,"is_preprint":false},{"pmid":"26706283","id":"PMC_26706283","title":"Norrin mediates angiogenic properties via the induction of insulin-like growth factor-1.","date":"2015","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/26706283","citation_count":18,"is_preprint":false},{"pmid":"15068782","id":"PMC_15068782","title":"Norrin and frizzled; a new vein for the eye.","date":"2004","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/15068782","citation_count":18,"is_preprint":false},{"pmid":"19137075","id":"PMC_19137075","title":"Norrin attenuates protease-mediated death of transformed retinal ganglion cells.","date":"2009","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/19137075","citation_count":18,"is_preprint":false},{"pmid":"12792823","id":"PMC_12792823","title":"ErbB2 and the antimetastatic nm23/NDP kinase in regulating serum induced breast cancer invasion.","date":"2003","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12792823","citation_count":18,"is_preprint":false},{"pmid":"33189676","id":"PMC_33189676","title":"Ethacrynic acid, a loop diuretic, suppresses epithelial-mesenchymal transition of A549 lung cancer cells via blocking of NDP-induced WNT signaling.","date":"2020","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/33189676","citation_count":18,"is_preprint":false},{"pmid":"22364200","id":"PMC_22364200","title":"Melanocortin-1 receptor-mediated signalling pathways activated by NDP-MSH and HBD3 ligands.","date":"2012","source":"Pigment cell & melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/22364200","citation_count":17,"is_preprint":false},{"pmid":"18547247","id":"PMC_18547247","title":"Vascular changes in the cerebellum of Norrin /Ndph knockout mice correlate with high expression of Norrin and Frizzled-4.","date":"2008","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18547247","citation_count":16,"is_preprint":false},{"pmid":"35651932","id":"PMC_35651932","title":"Spectrum of Mutations in NDP Resulting in Ocular Disease; a Systematic Review.","date":"2022","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35651932","citation_count":16,"is_preprint":false},{"pmid":"9066703","id":"PMC_9066703","title":"Nm23/nucleoside diphosphate (NDP) kinase expression in human malignant melanomas: significance and implications in tumor biology.","date":"1997","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/9066703","citation_count":16,"is_preprint":false},{"pmid":"33865932","id":"PMC_33865932","title":"NDP-MSH treatment recovers marginal lungs during ex vivo lung perfusion (EVLP).","date":"2021","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/33865932","citation_count":15,"is_preprint":false},{"pmid":"26477637","id":"PMC_26477637","title":"NDP-α-MSH attenuates heart and liver responses to myocardial reperfusion via the vagus nerve and JAK/ERK/STAT signaling.","date":"2015","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/26477637","citation_count":15,"is_preprint":false},{"pmid":"30712280","id":"PMC_30712280","title":"NDP-MSH reduces oxidative damage induced by palmitic acid in primary astrocytes.","date":"2019","source":"Journal of neuroendocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/30712280","citation_count":15,"is_preprint":false},{"pmid":"38881609","id":"PMC_38881609","title":"Familial Exudative Vitreoretinopathy With and Without Pathogenic Variants of Norrin/β-Catenin Signaling Genes.","date":"2024","source":"Ophthalmology science","url":"https://pubmed.ncbi.nlm.nih.gov/38881609","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50724,"output_tokens":8021,"usd":0.136243,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17530,"output_tokens":5759,"usd":0.115812,"stage2_stop_reason":"end_turn"},"total_usd":0.252055,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"Norrin (NDP) functions as a high-affinity ligand for Frizzled-4 (Fz4) receptor, binding specifically to Fz4 and not other Frizzled family members, and activates the classical (canonical) Wnt/β-catenin pathway in an Fz4- and Lrp-dependent manner. Disease-associated variants of Norrin and Fz4 display signaling defects.\",\n      \"method\": \"Binding assays, cell-based canonical Wnt pathway reporter assays, genetic phenotype comparison between Norrin and Fz4 mutant mice and humans\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (binding assay, cell-based signaling assay, in vivo genetics), replicated across species, foundational study\",\n      \"pmids\": [\"15035989\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"TSPAN12 (tetraspanin-12) associates with the Norrin/Frizzled4 receptor complex, promotes multimerization of FZD4 and associated proteins, and selectively amplifies Norrin/β-catenin signaling but not Wnt/β-catenin signaling. TSPAN12 siRNA abolishes transcriptional responses to Norrin but not Wnt3A in retinal endothelial cells. TSPAN12 loss-of-function phenocopies Norrin, Fzd4, and Lrp5 mutant retinal vascular defects in mice.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, overexpression, mouse genetics (knockout), cell-based β-catenin reporter assays\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (Co-IP, siRNA, OE, in vivo mouse genetics), replicated finding, two independent labs (PMID 19837033 and PMID 28658627)\",\n      \"pmids\": [\"19837033\", \"28658627\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Norrin/Fz4/Lrp signaling acts specifically in endothelial cells to control retinal vascular growth and blood-brain barrier integrity. Sox17, a transcription factor upregulated by Norrin/Fz4/Lrp signaling, plays a central role in inducing the angiogenic program. Excessive Fz4 signaling disrupts embryonic angiogenesis.\",\n      \"method\": \"Conditional mouse genetics (endothelial-specific Fz4 deletion), cell culture Norrin/Fz4/Lrp signaling assays, gene expression analysis\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific conditional knockout with defined phenotypic readout plus mechanistic follow-up (Sox17 identification), rigorous in vivo and in vitro\",\n      \"pmids\": [\"19837032\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Norrin/Fz4 signaling in adult retinal and cerebellar endothelial cells maintains blood-retina barrier and blood-brain barrier function in a cell-autonomous manner, demonstrating ongoing plasticity and requirement for Frizzled signaling in mature CNS vascular barrier maintenance.\",\n      \"method\": \"Conditional gain- and loss-of-function mouse genetics, genetic mosaic analysis, vascular permeability assays\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo genetic gain and loss of function with specific barrier permeability readouts, multiple genetic models\",\n      \"pmids\": [\"23217714\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Crystal structure of Norrin in complex with Fz4 cysteine-rich domain (Fz4CRD) revealed that Norrin mimics Wnt for Frizzled recognition, using structurally distinct patches to contact Fz4. The structure maps separate binding sites on Norrin for Fz4 and Lrp5/6, and identifies a glycosaminoglycan (GAG) binding site spanning Norrin and Fz4CRD. Disease-associated mutations are explained by these structural findings.\",\n      \"method\": \"X-ray crystallography, small-angle X-ray scattering (SAXS), biophysical binding assays, cell-based signaling assays with mutants\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with functional validation by mutagenesis and cell-based assays, complementary SAXS, rigorous single study\",\n      \"pmids\": [\"26158506\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Crystal structure of Norrin reveals a unique dimeric architecture with each monomer adopting a cystine knot fold. The dimer interface is required for Fz4 activation. Norrin contains separate binding sites for Fz4 and for Lrp5/Lrp6 and induces formation of a ternary Norrin-Fz4-Lrp5/6 complex rather than inducing Fz4 dimerization.\",\n      \"method\": \"X-ray crystallography, site-directed mutagenesis, co-immunoprecipitation/binding assays, cell-based Wnt reporter assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure combined with mutagenesis and functional signaling assays in single rigorous study\",\n      \"pmids\": [\"24186977\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Norrin binds specifically to the Fz4 cysteine-rich domain (CRD) and does not detectably bind to 14 other mammalian Frizzled or secreted Frizzled-related protein CRDs. Norrin and Xenopus Wnt8 recognize largely overlapping regions on the Fz4 CRD. Norrin binding depends critically on three disulfide bonds forming the cystine knot and on a largely contiguous group of amino acids in the extended beta-sheet domain. Heparin enhances Norrin-CRD binding ~10-fold.\",\n      \"method\": \"Binding specificity assays across 14 Frizzled CRDs, site-directed mutagenesis of Norrin and Fz4/Fz8 chimeras, heparin competition binding\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — comprehensive mutagenesis combined with systematic binding specificity panel across 14 CRDs, multiple orthogonal methods\",\n      \"pmids\": [\"17158104\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Norrin is a secreted protein that forms disulfide-bonded oligomers (up to ~20 monomers) associated with the extracellular matrix. Cysteine-95 is required for oligomer formation beyond dimers. Disease-associated mutations (V60E, R121Q) reduce the amount of Norrin in the extracellular matrix of transfected cells.\",\n      \"method\": \"Pulse-chase radiolabeling, SDS-PAGE under reducing and non-reducing conditions, chemical crosslinking, site-directed mutagenesis of Cys95 and disease variants\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — biochemical reconstitution with mutagenesis in transfected cells, single lab but multiple orthogonal biochemical methods\",\n      \"pmids\": [\"9407136\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TSPAN12 acts as a co-receptor for the Norrin/FZD4 signaling complex: it interacts directly with FZD4 and NDP via its extracellular loops, enhances FZD4 ligand selectivity for NDP over Wnt, and is an essential component of the NDP receptor complex. FEVR-linked TSPAN12 mutations prevent its incorporation into the NDP receptor complex. TSPAN12 can rescue defects of FZD4 M105V (a mutation destabilizing NDP/FZD4 interaction) in vitro and in Xenopus.\",\n      \"method\": \"Co-immunoprecipitation, cell-based signaling assays, FEVR-mutant functional analysis, Xenopus rescue experiments\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, cell-based assay, in vivo Xenopus validation, FEVR mutation analysis, multiple methods in single study\",\n      \"pmids\": [\"28658627\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The flexible linker domain connecting the Fz4 CRD to the transmembrane domain directly contributes to high-affinity Norrin/Fz4 interaction (~10-fold higher affinity than CRD alone). Swapping the Fz4 linker with Fz5 linker abolishes Norrin signaling. Norrin binding induces conformational changes in the Fz4 linker and intracellular loop 3 (ICL3), and ICL3 mutations (L430A, L433A) reduce β-catenin signaling.\",\n      \"method\": \"Biophysical binding assays (SPR), hydrogen-deuterium exchange mass spectrometry, site-directed mutagenesis, cell-based β-catenin reporter assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — HDX-MS structural dynamics, binding assays, mutagenesis and functional signaling, multiple orthogonal methods in one study\",\n      \"pmids\": [\"30104375\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Norrin triggers FZD4 ubiquitination and induces internalization of the NDP/FZD4 receptor complex into the endo-lysosomal compartment via the multivesicular body (MVB)/ESCRT pathway. Inhibiting ubiquitinated cargo transport through the MVB pathway (dominant-negative VPS4 EQ) strongly impairs NDP/FZD4 β-catenin signaling in vitro and causes CNS angiogenesis and blood-CNS barrier defects in mice.\",\n      \"method\": \"Ubiquitination assays, endocytosis/trafficking assays, dominant-negative ESCRT overexpression (VPS4 EQ), in vitro signaling assays, in vivo mouse vascular phenotyping\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic trafficking experiments with dominant-negative validated both in vitro and in vivo, multiple orthogonal approaches\",\n      \"pmids\": [\"28675177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Norrin activates Wnt/β-catenin signaling in Müller glia, which then induces neuroprotective growth factors (FGF2, BDNF, CNTF, LEGF, LIF, EDN2). Conditioned medium from Norrin-treated Müller cells increases survival of RGC-5 cells. These neuroprotective effects on retinal ganglion cells can be blocked by DKK-1 (a Wnt/β-catenin inhibitor).\",\n      \"method\": \"Intravitreal injection of Norrin + NMDA in mice, DKK-1 inhibitor experiments, primary Müller cell culture, conditioned medium transfer to RGC-5 cells, western blot and gene expression analysis\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo and in vitro with DKK-1 blockade, conditioned medium transfer, single lab, multiple methods\",\n      \"pmids\": [\"20427659\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Norrin stimulates proliferation, viability, migration, and tube formation of microvascular endothelial cells in vitro. These effects are blocked by DKK-1. Norrin induces angiopoietin-2 (Ang-2) expression, and inhibitory antibodies against Ang-2 suppress Norrin's proliferative effects, placing Ang-2 as a downstream mediator.\",\n      \"method\": \"In vitro endothelial cell assays (proliferation, migration, tube formation), DKK-1 inhibition, anti-Ang-2 antibody inhibition, transgenic mouse OIR model\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple in vitro functional assays with DKK-1 pathway blockade and Ang-2 antibody inhibition, in vivo transgenic validation\",\n      \"pmids\": [\"20053900\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Norrin acts as a ligand for LGR4 receptor and stimulates Wnt signaling mediated by LGR4 (but not LGR5 or LGR6) in mammalian cells. Binding studies showed interactions between Norrin and LGR4, LGR5, and LGR6, but only LGR4 mediates signaling. Different Norrie disease mutations can be categorized by defects in signaling through FZD4 vs. LGR4 vs. BMP antagonism pathways.\",\n      \"method\": \"Cell-based Wnt signaling assays, binding studies, site-directed mutagenesis categorizing disease mutants\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-based signaling and binding assays with multiple receptor comparisons, mutagenesis, single lab\",\n      \"pmids\": [\"23444378\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Wnt7a and Norrin systems show partial redundancy in maintaining the blood-brain barrier and blood-retina barrier. Combined loss of Wnt7a and Norrin (or Wnt7a and Fz4) produces far more severe BBB defects than individual losses. Tspan12 functions as a coactivator less potent than Norrin in BBB maintenance, consistent with a model where Tspan12 amplifies Norrin signal amplitude in endothelial cells.\",\n      \"method\": \"Compound conditional knockout mouse genetics, BBB/BRB permeability assays, epistasis analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — rigorous compound conditional genetic epistasis in vivo with quantitative barrier assays, multiple genetic combinations tested\",\n      \"pmids\": [\"30478038\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"A molecularly defined subset of cortical astroglia (enriched in layer V) expresses and secretes Norrin. Astrocytic Norrin regulates neuronal dendrites and dendritic spines; loss of Norrin (as in Norrie disease) contributes to cortical dendritic spine loss.\",\n      \"method\": \"Transgenic mice with astroglia-specific promoter, transcriptomic analysis, histological analysis, loss-of-function dendritic spine quantification\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function with specific structural neuronal readout (spine density), transcriptomic confirmation of expression, single lab\",\n      \"pmids\": [\"30936556\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Norrin protected blood-brain barrier integrity after subarachnoid hemorrhage via Frizzled-4 receptor activation, which promotes β-catenin nuclear translocation and enhances expression of tight junction proteins Occludin, VE-Cadherin, and ZO-1. These effects were abolished by Frizzled-4 siRNA pretreatment.\",\n      \"method\": \"Rat subarachnoid hemorrhage model, intracerebroventricular Norrin administration, Frizzled-4 siRNA knockdown, BBB permeability assays, western blot, immunofluorescence\",\n      \"journal\": \"Stroke\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown of receptor abolishes Norrin effect, in vivo model with functional readouts, single lab\",\n      \"pmids\": [\"25550365\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Norrin restores blood-retinal barrier properties after VEGF-induced permeability in a β-catenin-dependent manner. VEGF promotes Norrin responsiveness by increasing TSPAN12 at cell membranes via an MEK/ERK-dependent mechanism. Norrin and VEGF together (but not separately) are required for enriched claudin-5 localization at tight junctions. GSK-3α/β inhibition does not restore BRB properties, suggesting the mechanism is not through GSK-3 inhibition alone.\",\n      \"method\": \"In vitro primary endothelial cell barrier assays (electrical resistance, RITC-dextran permeability), intravitreal co-injection in diabetic rats, western blot, β-catenin reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro and in vivo barrier assays, pathway inhibitor experiments, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"32086377\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Ectopic transgenic expression of Norrin under a lens-specific promoter restores normal retinal vascular network formation in Norrie disease (Ndp knockout) mice, rescuing the failure of deep capillary layer formation. Lenses expressing ectopic Norrin induce proliferation of co-cultured microvascular endothelial cells in vitro.\",\n      \"method\": \"Transgenic rescue in Ndp knockout mice, retinal vascular morphology, ERG functional analysis, in vitro co-culture endothelial proliferation assay\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo transgenic rescue of specific vascular phenotype with functional (ERG) readout, plus in vitro proliferation assay, single lab but strong rescue experiment\",\n      \"pmids\": [\"15716406\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Norrin is expressed in Müller glia in the retina and activates canonical Wnt/β-catenin signaling through Frizzled-4 receptors. Loss of Norrin or Frizzled-4 prevents intraretinal capillary formation during developmental angiogenesis. Norrin stimulates endothelial cell proliferation in the superficial retinal vascular plexus, and loss of Norrin reduces proliferation of isolectin B4-positive endothelial cells. Elevated mural cell coverage in Ndp knockout mice is associated with altered PDGFβ and PDGFRβ expression.\",\n      \"method\": \"Ndp knockout mouse morphometric analysis, DAPT Notch inhibition, BrdU in vivo proliferation assays, PDGF pathway expression analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo knockout with quantitative vascular morphometry and proliferation assays, single lab\",\n      \"pmids\": [\"22394677\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In FZD4 CRD mutants associated with FEVR (C45Y, Y58C, C204R), Norrin binding to FZD4 is abolished and FZD4-mediated Wnt/β-catenin signaling is abrogated. In vivo validation in Xenopus embryos showed these FZD4 mutations disrupt Norrin/β-catenin signaling as evidenced by decreased Siamois and Xnr3 expression.\",\n      \"method\": \"Cell-surface and overlay binding assays, luciferase reporter assays in HEK293, in vivo Xenopus β-catenin target gene expression\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — binding and signaling assays with disease mutants, in vivo Xenopus validation, single lab\",\n      \"pmids\": [\"21177847\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Missense mutations in NDP found in FEVR patients caused variable but moderate reductions (rather than complete abolishment) in Norrin signaling activity in a Topflash reporter assay. Norrin mutants examined demonstrated impaired cell surface binding to FZD4, and some may have partially lost ability to form a complex with high molecular weight material(s). No single-missense Norrin mutant showed complete loss of signaling.\",\n      \"method\": \"Norrin-dependent Topflash reporter assay, cell surface binding assay, protein electrophoresis\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic functional analysis of multiple patient variants with both binding and signaling assays, single lab\",\n      \"pmids\": [\"17955262\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Glutamatergic neuronal activity regulates retinal angiogenesis and blood-retinal barrier maturation by modulating endothelial Norrin/β-catenin signaling. In Vglut1-/- retinas (where neurons fail to release glutamate), Norrin expression and endothelial Norrin/β-catenin signaling are downregulated; in Gnat1-/- retinas (excessive glutamate), they are upregulated. Pharmacological activation of endothelial Norrin/β-catenin signaling in Vglut1-/- retinas rescues deep plexus angiogenesis and paracellular BRB maturation defects.\",\n      \"method\": \"In vivo mouse genetic studies (Vglut1-/-, Gnat1-/- knockouts), scRNA-seq, pharmacological Norrin/β-catenin pathway activation, vascular morphometry and permeability assays\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with specific pathway rescue (pharmacological activation), scRNA-seq, multiple orthogonal methods in one rigorous study\",\n      \"pmids\": [\"38599212\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Dermal papilla cells (DPCs) stimulated by extracellular vesicles from activated dermal fibroblasts upregulate and secrete Norrin via the NDP gene, which then activates the β-catenin pathway in follicular keratinocytes in a non-cell-autonomous manner to promote hair follicle growth. FZD4 protein (delivered by EV) was required to potentiate Norrin effects.\",\n      \"method\": \"Transcriptomic analysis of DPCs, siRNA knockdown, β-catenin reporter assays, hair follicle ex vivo growth assays, EV transfer\",\n      \"journal\": \"Stem cells (Dayton, Ohio)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transcriptomics plus functional cell-based assays and ex vivo model, single lab\",\n      \"pmids\": [\"31237401\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In glioblastoma, Norrin signals through FZD4 to activate canonical Wnt signaling in ASCL1-low GSCs (tumor-suppressive effect) but promotes Notch signaling independently of WNT in ASCL1-high GSCs (tumor-promoting effect). Forced ASCL1 expression reversed tumor-suppressive effects of Norrin in ASCL1-low GSCs.\",\n      \"method\": \"GBM stem cell culture, NDP/FZD4 manipulation, Notch and Wnt pathway reporter assays, ASCL1 overexpression rescue, functional growth assays\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-based gain/loss of function with pathway-specific readouts and rescue experiment, single lab\",\n      \"pmids\": [\"32182224\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"A tetravalent bispecific antibody (F4L5.13) designed to induce FZD4 and LRP5 proximity triggers β-catenin signaling in endothelial cells, rescues retinal angiogenesis and barrier function in Tspan12-/- mice, and normalizes neovascularization in an OIR model, demonstrating that forced FZD4-LRP5 co-engagement is sufficient to recapitulate Norrin/FZD4/LRP5 signaling.\",\n      \"method\": \"Antibody engineering, cell-based β-catenin signaling assays, Tspan12-/- mouse retinal phenotype rescue, OIR mouse model, vascular permeability assays\",\n      \"journal\": \"EMBO molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro and in vivo rescue with mechanistic antibody tool demonstrating sufficiency of FZD4-LRP5 co-engagement, single lab\",\n      \"pmids\": [\"34105895\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Female mice homozygous for Ndp knockout exhibit near-complete infertility due to defects in vascular development and decidualization in the uterus from E7 onwards, demonstrating a role for Norrin in female reproductive tissue vascular development.\",\n      \"method\": \"Ndp knockout mouse model, histological analysis, RNA in situ hybridization, RT-PCR expression analysis of uteri, deciduae, and human placenta\",\n      \"journal\": \"Genesis (New York, N.Y. : 2000)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with specific histological and vascular phenotypic readout, expression confirmed by RT-PCR, single lab\",\n      \"pmids\": [\"16035034\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Norrin activates Wnt/β-catenin signaling and endothelin-2 (EDN2) signaling to protect photoreceptors from light-induced damage. The protective effects were abolished by intravitreal injection of DKK-1 (Wnt/β-catenin inhibitor) or BQ788 (EDN receptor B antagonist), establishing that both Wnt/β-catenin and EDN2 signaling are required for Norrin-mediated photoreceptor protection.\",\n      \"method\": \"Transgenic Norrin-overexpressing mice (Rpe65-Norrin), light damage model, intravitreal DKK-1 and BQ788 injections, ERG functional assays, apoptosis quantification\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo pathway blockade with two different inhibitors to dissect mechanisms, transgenic model, functional readouts, single lab\",\n      \"pmids\": [\"23009755\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Norrin induces IGF-1 expression via activation of the Wnt/β-catenin signaling pathway in Müller cells and endothelial cells. Inhibition of IGF-1 with antibodies significantly attenuates Norrin-mediated vascular repair in the OIR model, establishing IGF-1 as a downstream mediator of Norrin's angiogenic properties.\",\n      \"method\": \"Transgenic Norrin-overexpressing mice (βB1-Norrin), OIR model, DKK-1 inhibition, anti-IGF-1 antibody intravitreal injection, gene expression analysis\",\n      \"journal\": \"Experimental eye research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — inhibitory antibody intervention establishing downstream mediator role, in vivo and in vitro, single lab\",\n      \"pmids\": [\"26706283\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Norrin (NDP) is a secreted cystine-knot growth factor that forms disulfide-linked dimers/oligomers associated with the extracellular matrix; it acts as an atypical, high-affinity ligand for Frizzled-4 (FZD4) receptor — specifically binding its cysteine-rich domain in a manner that mimics Wnt — and, together with the LRP5/6 co-receptors and the tetraspanin co-receptor TSPAN12, assembles a ternary signaling complex that activates the canonical β-catenin/Wnt pathway in vascular endothelial cells of the retina and CNS to drive angiogenesis, blood-retina and blood-brain barrier formation and maintenance, and (via β-catenin-dependent induction of growth factors such as FGF2, BDNF, Ang-2, and IGF-1 in Müller glia) neuroprotection of retinal ganglion cells; Norrin-induced FZD4 ubiquitination and endo-lysosomal trafficking through the ESCRT/MVB pathway is required for full signaling, and Norrin also signals through LGR4 and, in some contexts, activates Notch independently of Wnt.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"Norrin (NDP) is a secreted cystine-knot growth factor that drives canonical Wnt/\\u03b2-catenin signaling in vascular endothelium to control CNS and retinal angiogenesis and blood-barrier formation and maintenance [#0, #2, #3]. Biochemically it is secreted as disulfide-bonded dimers and higher-order oligomers associated with the extracellular matrix, with Cys95 required for oligomerization beyond dimers [#7]; each monomer adopts a cystine-knot fold, and the dimer interface is required for receptor activation [#5]. Norrin acts as an atypical, Wnt-mimetic ligand that binds specifically and with high affinity to the cysteine-rich domain (CRD) of Frizzled-4 and not to other Frizzled CRDs, contacting Fz4 through patches that overlap the Wnt-recognition surface while using a separate site to engage the LRP5/6 co-receptor, thereby nucleating a ternary Norrin\\u2013Fz4\\u2013LRP5/6 complex rather than inducing Fz4 dimerization [#0, #4, #5, #6]. Signaling output is selectively amplified by the tetraspanin co-receptor TSPAN12, which interacts directly with FZD4 and Norrin, promotes receptor-complex multimerization, and confers ligand selectivity for Norrin over Wnt [#1, #8]. Norrin-induced FZD4 ubiquitination and trafficking of the receptor complex into the endo-lysosomal/MVB compartment via the ESCRT pathway is required for full \\u03b2-catenin signaling and for normal CNS vascular and barrier development [#10]. Downstream, endothelial \\u03b2-catenin activation induces an angiogenic and barrier program\\u2014including Sox17 and tight-junction proteins\\u2014while in Müller glia Norrin/\\u03b2-catenin drives secretion of neuroprotective and angiogenic factors (FGF2, BDNF, Ang-2, IGF-1) that support endothelial growth and retinal neuron survival [#2, #11, #12, #28]. Loss-of-function and disease-associated NDP and FZD4 variants disrupt secretion, receptor binding, or signaling, and transgenic re-expression of Norrin rescues retinal vascular defects in Ndp-null mice, establishing Norrin as causative for the inherited vascular retinopathies of the Norrie disease/FEVR spectrum [#7, #18, #20, #21]. Beyond the vascular Wnt axis, Norrin also signals through the LGR4 receptor and, in glioblastoma stem cells, can activate Notch independently of Wnt depending on ASCL1 status [#13, #24].\"\n  ,\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Established the secreted, oligomeric, ECM-associated nature of Norrin before its receptor was known, defining the biochemical form in which the ligand acts.\",\n      \"evidence\": \"Pulse-chase radiolabeling, non-reducing SDS-PAGE, crosslinking and mutagenesis of Cys95 and disease variants in transfected cells\",\n      \"pmids\": [\"9407136\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify a receptor or signaling pathway\", \"Functional consequence of oligomerization for signaling not tested\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identified Norrin as a high-affinity, Frizzled-4-specific ligand that activates canonical Wnt/\\u03b2-catenin signaling in an Fz4/Lrp-dependent manner, unifying NDP and FZD4 genetics into one pathway.\",\n      \"evidence\": \"Binding assays, cell-based \\u03b2-catenin reporter assays, and comparison of Norrin and Fz4 mutant mice and humans\",\n      \"pmids\": [\"15035989\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of Fz4 selectivity not resolved\", \"Co-receptor requirements beyond Lrp not defined\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Defined the structural determinants of Norrin\\u2013Fz4 specificity, showing it recognizes the Fz4 CRD over 13 other CRDs through the cystine knot and overlaps the Wnt8 binding region, with heparin enhancing binding.\",\n      \"evidence\": \"Binding specificity panel across 14 Frizzled CRDs, mutagenesis of Norrin and Fz4/Fz8 chimeras, heparin competition\",\n      \"pmids\": [\"17158104\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic structure not yet determined\", \"Role of GAG binding in vivo unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Showed Norrin/Fz4/Lrp signaling acts cell-autonomously in endothelium to drive retinal vascular growth and barrier integrity, identifying Sox17 as a transcriptional effector of the angiogenic program.\",\n      \"evidence\": \"Endothelial-specific conditional Fz4 deletion, cell-culture signaling assays, gene expression analysis\",\n      \"pmids\": [\"19837032\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full downstream transcriptional network not mapped\", \"Mechanism of barrier-specific output not resolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identified TSPAN12 as a component that multimerizes the Norrin/FZD4 complex and selectively amplifies Norrin (not Wnt) \\u03b2-catenin signaling, explaining ligand-specific pathway control.\",\n      \"evidence\": \"Co-IP, siRNA knockdown, overexpression, mouse knockout phenocopy, \\u03b2-catenin reporter assays\",\n      \"pmids\": [\"19837033\", \"28658627\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of Norrin-vs-Wnt selectivity not yet structural\", \"Stoichiometry of the multimeric complex unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Connected Norrin/\\u03b2-catenin signaling to non-cell-autonomous outputs: Müller-glial induction of neuroprotective factors and endothelial proliferation/angiogenesis mediated by Ang-2.\",\n      \"evidence\": \"Intravitreal Norrin, DKK-1 blockade, conditioned-medium transfer, anti-Ang-2 inhibition, in vitro endothelial assays, OIR model\",\n      \"pmids\": [\"20427659\", \"20053900\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"RGC-5 line and conditioned-medium model are indirect\", \"Relative contributions of individual secreted factors not dissected\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Demonstrated a continuing requirement for Norrin/Fz4 signaling in mature CNS endothelium for ongoing blood-retina and blood-brain barrier maintenance, not just development.\",\n      \"evidence\": \"Conditional gain/loss-of-function and mosaic mouse genetics with vascular permeability assays\",\n      \"pmids\": [\"23217714\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular targets sustaining the mature barrier not fully enumerated\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Determined the Norrin crystal structure, establishing a cystine-knot dimer with separate Fz4 and Lrp5/6 sites that assembles a ternary complex, providing the mechanistic framework for receptor engagement.\",\n      \"evidence\": \"X-ray crystallography, mutagenesis, binding assays, Wnt reporter assays\",\n      \"pmids\": [\"24186977\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Co-complex structure with receptors not yet solved\", \"Conformational changes in Fz4 upon binding not visualized\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Revealed receptor diversity by showing Norrin also functions as an LGR4-specific Wnt agonist, and that disease mutations can be partitioned by which downstream pathway they impair.\",\n      \"evidence\": \"Cell-based Wnt signaling and binding assays across LGR4/5/6, mutagenesis of disease variants\",\n      \"pmids\": [\"23444378\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo physiological role of Norrin\\u2013LGR4 signaling not established\", \"Relationship to FZD4 axis unclear\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Provided the Norrin\\u2013Fz4CRD co-structure, showing Wnt mimicry through distinct contact patches, mapped separate Lrp5/6 and GAG sites, and explained disease mutations structurally.\",\n      \"evidence\": \"X-ray crystallography, SAXS, biophysical binding and cell-based signaling assays with mutants\",\n      \"pmids\": [\"26158506\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full ternary receptor complex not captured\", \"Transmembrane signal transmission not addressed\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Established TSPAN12 as a direct co-receptor whose extracellular loops bind FZD4 and Norrin to confer ligand selectivity, and showed FEVR mutations exclude it from the complex.\",\n      \"evidence\": \"Reciprocal Co-IP, cell-based signaling, FEVR-mutant analysis, Xenopus rescue\",\n      \"pmids\": [\"28658627\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of TSPAN12 within the complex unknown\", \"Quantitative contribution to receptor multimerization unresolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Showed that Norrin-triggered FZD4 ubiquitination and ESCRT/MVB-dependent endo-lysosomal trafficking is required for full \\u03b2-catenin signaling and CNS vascular development, adding a post-receptor regulatory layer.\",\n      \"evidence\": \"Ubiquitination/trafficking assays, dominant-negative VPS4 EQ, in vitro signaling and in vivo mouse vascular phenotyping\",\n      \"pmids\": [\"28675177\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the responsible E3 ligase not defined\", \"How trafficking enhances \\u03b2-catenin output mechanistically unclear\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Refined the receptor mechanism by showing the Fz4 stalk linker contributes ~10-fold to Norrin affinity and that binding induces conformational changes in the linker and ICL3 important for signaling.\",\n      \"evidence\": \"SPR binding, HDX-MS, mutagenesis (linker swaps, ICL3 mutants), \\u03b2-catenin reporter assays\",\n      \"pmids\": [\"30104375\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How ICL3 changes couple to intracellular effectors not defined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Defined functional redundancy between the Norrin and Wnt7a barrier systems, and positioned TSPAN12 as a less-potent coactivator that tunes Norrin signal amplitude.\",\n      \"evidence\": \"Compound conditional knockout epistasis, BBB/BRB permeability assays\",\n      \"pmids\": [\"30478038\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Regional/temporal division of labor between ligands not fully mapped\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Extended Norrin biology beyond vasculature, showing astroglial-secreted Norrin shapes neuronal dendrites/spines and that follicular Norrin acts non-cell-autonomously to drive hair growth.\",\n      \"evidence\": \"Astroglia-specific transgenics with spine quantification; dermal papilla transcriptomics, siRNA, \\u03b2-catenin reporters, ex vivo hair follicle growth and EV transfer\",\n      \"pmids\": [\"30936556\", \"31237401\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor/co-receptor identity in these contexts not fully defined\", \"Single-lab observations\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Revealed context-dependent pathway switching: Norrin activates Wnt in ASCL1-low glioblastoma stem cells but Notch independently of Wnt in ASCL1-high cells, with opposite tumor consequences; and VEGF licenses Norrin barrier responses via MEK/ERK-driven TSPAN12 surface expression.\",\n      \"evidence\": \"GSC cultures with NDP/FZD4 manipulation and ASCL1 rescue; endothelial barrier assays with VEGF co-treatment, pathway inhibitors, diabetic rat injections\",\n      \"pmids\": [\"32182224\", \"32086377\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular switch determining Wnt-vs-Notch output unclear\", \"GSK-3-independent barrier mechanism not fully resolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Demonstrated sufficiency of the core receptor logic: a bispecific antibody forcing FZD4\\u2013LRP5 proximity recapitulates Norrin signaling and rescues Tspan12-/- and OIR vascular defects.\",\n      \"evidence\": \"Antibody engineering, \\u03b2-catenin assays, Tspan12-/- rescue, OIR model, permeability assays\",\n      \"pmids\": [\"34105895\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether forced proximity reproduces full trafficking-dependent signaling not tested\", \"Single lab\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Placed Norrin signaling under neuronal-activity control, showing glutamatergic activity tunes endothelial Norrin/\\u03b2-catenin signaling to coordinate angiogenesis and barrier maturation with neural function.\",\n      \"evidence\": \"Vglut1-/- and Gnat1-/- mouse genetics, scRNA-seq, pharmacological pathway activation, vascular morphometry and permeability\",\n      \"pmids\": [\"38599212\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signal relay from glutamate sensing to Norrin expression not molecularly defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the choice between Norrin's distinct outputs (FZD4/\\u03b2-catenin vs LGR4 vs Notch) is determined in different cell contexts, and the identity of the FZD4 E3 ubiquitin ligase coupling trafficking to signal strength, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No defined molecular switch governing pathway selection\", \"FZD4 ubiquitin ligase unidentified\", \"In vivo role of Norrin-LGR4 axis untested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [0, 4, 5, 6, 13]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 8]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 5]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [6, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [7, 15, 23]},\n      {\"term_id\": \"GO:0031012\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 5, 9]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [2, 18, 19]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [10]}\n    ],\n    \"complexes\": [\"Norrin-FZD4-LRP5/6 ternary signaling complex\", \"Norrin/FZD4/TSPAN12 receptor complex\"],\n    \"partners\": [\"FZD4\", \"LRP5\", \"LRP6\", \"TSPAN12\", \"LGR4\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}